Justin Bowers
Stock Analyst at Deutsche Bank
(2.44)
# 2,391
Out of 4,818 analysts
49
Total ratings
40%
Success rate
2.29%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Hold | $310 → $325 | $341.29 | -4.77% | 3 | Nov 4, 2024 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $265 | $150.68 | +75.87% | 2 | Nov 1, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $28 → $23 | $5.86 | +292.83% | 3 | Aug 20, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $29 | $21.31 | +36.09% | 1 | Aug 19, 2024 | |
| AMED Amedisys | Downgrades: Hold | $101 | $94.27 | +7.14% | 11 | Jul 31, 2024 | |
| MEDP Medpace Holdings | Maintains: Hold | $395 → $336 | $302.69 | +11.00% | 2 | Jul 24, 2024 | |
| TXG 10x Genomics | Downgrades: Hold | $55 → $25 | $8.31 | +200.84% | 3 | Jul 10, 2024 | |
| RGEN Repligen | Upgrades: Buy | $180 → $155 | $145.40 | +6.60% | 2 | Jun 26, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $600 → $610 | $426.66 | +42.97% | 3 | Apr 25, 2024 | |
| TECH Bio-Techne | Maintains: Buy | $85 → $82 | $50.80 | +61.42% | 2 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $23 → $25 | $15.44 | +61.92% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $17 | $2.08 | +717.31% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $300 | $145.92 | +105.59% | 2 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $275 | $196.52 | +39.93% | 2 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $210.19 | +18.94% | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $290 | $115.89 | +150.25% | 1 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $46 | $16.58 | +177.44% | 5 | May 10, 2021 |
Waters
Nov 4, 2024
Maintains: Hold
Price Target: $310 → $325
Current: $341.29
Upside: -4.77%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $270 → $265
Current: $150.68
Upside: +75.87%
Fortrea Holdings
Aug 20, 2024
Maintains: Hold
Price Target: $28 → $23
Current: $5.86
Upside: +292.83%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $29
Current: $21.31
Upside: +36.09%
Amedisys
Jul 31, 2024
Downgrades: Hold
Price Target: $101
Current: $94.27
Upside: +7.14%
Medpace Holdings
Jul 24, 2024
Maintains: Hold
Price Target: $395 → $336
Current: $302.69
Upside: +11.00%
10x Genomics
Jul 10, 2024
Downgrades: Hold
Price Target: $55 → $25
Current: $8.31
Upside: +200.84%
Repligen
Jun 26, 2024
Upgrades: Buy
Price Target: $180 → $155
Current: $145.40
Upside: +6.60%
Thermo Fisher Scientific
Apr 25, 2024
Maintains: Buy
Price Target: $600 → $610
Current: $426.66
Upside: +42.97%
Bio-Techne
Apr 18, 2024
Maintains: Buy
Price Target: $85 → $82
Current: $50.80
Upside: +61.42%
Apr 18, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $15.44
Upside: +61.92%
Aug 8, 2023
Maintains: Buy
Price Target: $23 → $17
Current: $2.08
Upside: +717.31%
Jul 14, 2023
Maintains: Buy
Price Target: $280 → $300
Current: $145.92
Upside: +105.59%
Apr 27, 2023
Maintains: Buy
Price Target: $310 → $275
Current: $196.52
Upside: +39.93%
Dec 14, 2022
Initiates: Hold
Price Target: $250
Current: $210.19
Upside: +18.94%
Jul 14, 2022
Maintains: Buy
Price Target: $350 → $290
Current: $115.89
Upside: +150.25%
May 10, 2021
Maintains: Buy
Price Target: $42 → $46
Current: $16.58
Upside: +177.44%